Product
Bone marrow transplant
1 clinical trial
1 indication
Indication
Sickle Cell DiseaseClinical trial
Bone Marrow Transplantation HLA Haploidentical After a Reduced Intensity Conditioning and Prevention of GvHD Based on Post-transplant Cyclophosphamide Administration in Patients With Severe Sickle Cell DiseaseStatus: Active (not recruiting), Estimated PCD: 2024-03-01